47 results
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
be earned in whole or in part upon attainment of performance goals or other vesting criteria as the Administrator may determine pursuant to Section 10 … .
(z) “Performance Unit” means an Award which may be earned in whole or in part upon attainment of performance goals or other vesting criteria
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
and insulinoma patients is 5 years and 7 years, respectively.
DCCR tablets were formulated with the goals of improving the safety and bioavailability … profitable, and it is possible we will never achieve these goals. Our ability to obtain additional financing will depend on a number of factors, including
424B5
lqrxyf3 vqt
27 Sep 23
Prospectus supplement for primary offering
5:26pm
424B5
7lrprbuekp2
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
4jb5u12r6yhh gds72
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
afhzcro 723hgp
16 Jul 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-10.1
eoavo61rdeowusb3v
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
S-8
EX-4.2
7par5sadox27bbkz9
26 Jun 20
Registration of securities for employees
5:01pm